JAGX - Jaguar Health Inc
0.491
-0.100 -20.265%
Share volume: 1,211,987
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$0.59
-0.10
-0.17%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 55.389 M | 61.459 M | 58.466 M | 51.460 M | 48.268 M | 49.472 M | |
| Current Assets | 33.714 M | 40.111 M | 36.643 M | 30.439 M | 27.903 M | 29.402 M | |
| Inventories | 9.020 M | 9.556 M | 9.674 M | 10.555 M | 10.719 M | 10.628 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 11.671 M | 16.049 M | 13.269 M | 5.690 M | 2.207 M | 3.527 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 484.000 K | 488.000 K | 476.000 K | 452.000 K | 441.000 K | 483.000 K | |
| Other Assets | 21.191 M | 20.860 M | 21.347 M | 20.569 M | 19.924 M | 19.587 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 55.389 M | 61.459 M | 58.466 M | 51.460 M | 48.268 M | 49.472 M | |
| Total liabilities | 41.086 M | 42.396 M | 42.883 M | 48.145 M | 41.388 M | 45.113 M | |
| Total current liabilities | 17.814 M | 19.133 M | 19.874 M | 28.208 M | 29.218 M | 36.122 M | |
| Accounts Payable | 3.320 M | 4.093 M | 4.552 M | 7.028 M | 6.617 M | 8.443 M | |
| Other liabilities | 873.000 K | 812.000 K | 754.000 K | 998.000 K | 960.000 K | 918.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 21.719 M | 21.813 M | 21.660 M | 18.429 M | 10.742 M | 7.648 M | |
| Other liabilities | 873.000 K | 812.000 K | 754.000 K | 998.000 K | 960.000 K | 918.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 11.998 M | 16.906 M | 13.612 M | 1.782 M | 5.503 M | 3.142 M | |
| Common stock | 329.674 M | 344.155 M | 350.860 M | 359.428 M | 373.575 M | 380.836 M | |
| Retained earnings | -317.215 M | -326.707 M | -336.561 M | -356.946 M | -367.353 M | -376.855 M |